BioXcel Therapeutics Inc
BTAI
Market Cap$8.39M
Close$
$-1.08
173.1% downside
Current Fair Value
173.1% downsideOvervalued by 173.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.39 Million |
|---|---|
| Enterprise Value | $81.58 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-23.51 |
| Beta | 0.08 |
| Outstanding Shares | 3,039,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.08 |
|---|---|
| PEG | 0.11 |
| Price to Sales | - |
| Price to Book Ratio | -0.05 |
| Enterprise Value to Revenue | 35.84 |
| Enterprise Value to EBIT | -1.09 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 1.26 |
| Debt to Equity | -1.11 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About BioXcel Therapeutics Inc
CEO: Vimal Mehta